CTSO Cytosorbents Corp Forecast, Technical & Fundamental Analysis
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery... Show more
CTSO is expected to report earnings to fall 17.40% to -4 cents per share on August 06
Q2'26
Est.
$-0.04
Q1'26
Missed
by $0.01
Q4'25
Missed
by $0.03
Q3'25
Beat
by $0.01
Q2'25
Missed
by $0.01
The last earnings report on May 13 showed earnings per share of -5 cents, missing the estimate of -3 cents. With 41.53K shares outstanding, the current market capitalization sits at 22.68M.
A.I. Advisor
published General Information
General Information
a developer of products to support healthcare professionals in the treatment of complex medical conditions
A.I.dvisor tells us that CTSO and TMDX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTSO and TMDX's prices will move in lockstep.
The Aroon Indicator for CTSO entered a downward trend on July 31, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 281 similar instances where the Aroon Indicator formed such a pattern. In of the 281 cases the stock moved lower. This puts the odds of a downward move at .
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTSO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Momentum Indicator moved above the 0 level on July 31, 2026. You may want to consider a long position or call options on CTSO as a result. In of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CTSO just turned positive on July 06, 2026. Looking at past instances where CTSO's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CTSO advanced for three days, in of 246 cases, the price rose further within the following month. The odds of a continued upward trend are .
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.341) is normal, around the industry mean (10.948). P/E Ratio (0.000) is within average values for comparable stocks, (63.950). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.042). CTSO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (0.609) is also within normal values, averaging (35.779).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CTSO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTSO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
